Cancer Invest. 2021 Apr;39(4):285-296.doi: 10.1080/07357907.2021.1894570. Epub 2021 Mar 11.
2021-10-19Cancer Invest. 2021 Apr;39(4):285-296.doi:10.1080/07357907.2021.1894570. Epub 2021 Mar 11. The Targeting Effect of Cetuximab Combined with PD-L1 Blockade against EGFR-Expressing Tumors in a Tailored CD16-CAR T-Cell Reporter System西妥昔单抗联合PD-L1阻滞剂对肿瘤细胞的靶向作用